It’s no secret that the Rare Disease Clinical Trials industry is struggling to keep operational costs under control. Between 2008 and 2013, clinical trial costs went up by a full 60%, and Tufts research indicates that the average cost of a new prescription drug approval is now more than $2.6 million. It’s worth pointing out […]
Category Archives: Blogs
The Future of Tech in Nutraceuticals Industry
A global industry survey conducted by Nutrify Today, a nutraceuticals i2c (ideas to commercialization) platform, has found that there is growing optimism around the food and nutrition industry globally and technologies like artificial intelligence will further drive the market growth. The study also sees India as a leading player in the industry that will harness […]
Blockbuster drugs, building and sustaining billion-dollar brands
A blockbuster drug is a very popular drug that generates annual sales of $1 billion or more for the company that sells it. Common blockbuster drugs are Vioxx, Lipitor, and Zoloft. Blockbuster drugs are used for common ailments, such as diabetes, cholesterol, high blood pressure, and cancer, that many individuals face. Examples in recent years […]
Pharma Marketing: How to Successfully Market in the Pharma Industry
The Market in the Pharma Industry is $900 billion and this figure is fully expected to exceed $1,1 trillions in the next few years. In fact, recent studies show the industry is growing at a rate of 5%, which is just behind the two other major healthcare segments – medical services and equipment. As a […]
Has the pharma industry forgotten the role of Knowledge marketing?
Role of Knowledge marketing is a process whereby companies identify, store, share, and reuse their own data, external information and most important the business knowledge and experience of employees. Knowledge management is not just about technology, but also about implementing new business processes. It’s a fast-paced marketplace out there for pharmaceutical, biotech and medical device […]
Procedures for product recall in pharmaceutical industry
A drug product recall is a request to return to the maker a batch or an entire production run of a product, usually due to the discovery of consumer safety issues. Recalls are costly to a company because they often loss their company name form the consumer. The reason for drug product recall may be […]
The Future is Phygital: Physical and Digital for pharma marketers.
What is phygital? The future is Phygital Phygital simply combines the words physical and digital to create a new word: phygital. The future is Phygital, while it’s not exactly clear who coined the term, we started using it at the height of the COVID-19 pandemic. Why? Because we noticed more companies quickly adjusting their strategies […]
Ways pharma marketers can boost physician engagement via telehealth.
Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information. In fact, they are engaging with digital education platforms more than ever before, suggesting that these channels could fill the gaps now left in pharma’s marketing program i.e. pharma […]
How Cancer Fools the Immune System into Developing the Disease
Cancer is a tricky disease, and a recent study from the Icahn School of Medicine at Mount Sinai shows just how cunning the disease can be. Research shows that cancer can fool Immune System, which normally repair the body, into actually helping develop the disease. The research, which was published in Nature, showed that early-stage […]
Marketing to the Rare Diseases Community
Diagnosing and treating a rare disease is difficult on a good day. Length of time to diagnosis (often more than five years), lack of therapies (there are effective therapies for less than five percent of 7,000 known rare diseases) and small patient populations (Rare Diseases Community) all lead to significant challenges for the healthcare industry […]